News Buzz: Pepco Holdings, Inc. (NYSE:POM), Sirius XM Holdings Inc. (NASDAQ:SIRI), DryShips, Inc. (NASDAQ:DRYS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA),

Pepco Holdings, Inc. (NYSE:POM) reported that, GAAP net income from continuing operations was $318 million or $1.25 per share, as compared to $242 million, or 96 cents per share in the prior year. Excluding items that we believe are not representative of ongoing business operations, 2015 adjusted net income from continuing operations would have been $325 million or $1.28 per share, as compared to $321 million, or $1.27 per share in the prior year.

Pepco Holdings, Inc. (NYSE:POM) belongs to Utilities sector. Its net profit margin is 4.60% and weekly performance is -0.64%. On last trading day company shares ended up at $26.52. Pepco Holdings, Inc. (NYSE:POM) distance from 50-day simple moving average (SMA50) is 2.30%.

Sirius XM Holdings Inc. (NASDAQ:SIRI) began its 15th season covering NASCAR with comprehensive coverage of the 58th running of the DAYTONA 500 on FEBRUARY 21st, including the live race broadcast, in-car audio from some of the sport’s top drivers, and daily coverage from DAYTONA INTERNATIONAL SPEEDWAY on SIRIUSXM NASCAR RADIO (channel 90).

Sirius XM Holdings Inc. (NASDAQ:SIRI) belongs to Services sector. Its net profit margin is 11.20% and weekly performance is 3.07%. On last trading day company shares ended up at $3.69. Sirius XM Holdings Inc. (NASDAQ:SIRI) distance from 50-day simple moving average (SMA50) is 1.25%.

DryShips, Inc. (NASDAQ:DRYS) shareholders approved a proposal to effect one or more reverse stock splits at a ratio of not less than one-for-two and not more than one-for-100. The exact ratio will be set at a whole number within this range to be determined by the board.

DryShips, Inc. (NASDAQ:DRYS) shares fell -1.62% in last trading session and ended the day at $0.10. DRYS Gross Margin is 56.90% and its return on assets is -37.50%. DryShips, Inc. (NASDAQ:DRYS) quarterly performance is -31.13%.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Market Beat.com reports. The brokerage currently has a $1.75 price target on the biopharmaceutical company’s stock.

On 25 February, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares fell -0.66% and was closed at $1.50. ARNA EPS growth in last 5 year was 31.20%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) year to date (YTD) performance is -21.05%.

AK Steel Holding Corporation (NYSE:AKS) said that it will increase base prices for all of its stainless steel products, effective with shipments on March 1, 2016. For commodity sheet and strip, specialty sheet and strip, and pipe and tube sheet and strip products, the increase will be achieved through a reduction in the functional discount of two percentage points.

AK Steel Holding Corporation (NYSE:AKS) ended the last trading day at $2.56. Company weekly volatility is calculated as 5.63% and price to cash ratio as 8.04. AK Steel Holding Corporation (NYSE:AKS) showed a weekly performance of -0.39%.

Leave a Reply

Your email address will not be published. Required fields are marked *